 Pharmacology
"Pharmacology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The study of the origin, nature, properties, and actions of drugs and their effects on living organisms.
| Descriptor ID |
D010600
|
| MeSH Number(s) |
H01.158.703 H02.628
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pharmacology".
Below are MeSH descriptors whose meaning is more specific than "Pharmacology".
This graph shows the total number of publications written about "Pharmacology" by people in this website by year, and whether "Pharmacology" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 1 | 3 | | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pharmacology" by people in Profiles.
-
Shipkova M, Christians U. Improving Therapeutic Decisions: Pharmacodynamic Monitoring as an Integral Part of Therapeutic Drug Monitoring. Ther Drug Monit. 2019 04; 41(2):111-114.
-
Barton M, Little HJ, Vaughan-Jones RD, Daniels S, Dashwood MR, Tsui JC. Sidney George Shaw, DPhil (1948-2017). Physiol Res. 2018 06 27; 67(Suppl 1):S27-S35.
-
Franson KL, Dubois EA, de Kam ML, Cohen AF. Measuring learning from the TRC pharmacology E-Learning program. Br J Clin Pharmacol. 2008 Jul; 66(1):135-41.
-
Camidge DR, Davies MJ, Laud PJ, Marshall AL, Cockerill M, Smith PD, Hughes AM. Factors determining the optimal body site and method for obtaining punch biopsies of human skin as a tissue in which to assess pharmacodynamic and pharmacokinetic endpoints in drug development studies. Cancer Chemother Pharmacol. 2006 Jan; 57(1):52-8.
-
Xiao YD, Clauset A, Harris R, Bayram E, Santago P, Schmitt JD. Supervised self-organizing maps in drug discovery. 1. Robust behavior with overdetermined data sets. J Chem Inf Model. 2005 Nov-Dec; 45(6):1749-58.
-
Lin M, Aquilante C, Johnson JA, Wu R. Sequencing drug response with HapMap. Pharmacogenomics J. 2005; 5(3):149-56.
-
Walgren JL, Thompson DC. Application of proteomic technologies in the drug development process. Toxicol Lett. 2004 Apr 01; 149(1-3):377-85.
-
Dubois EA, Franson KL, van Gerven JM, Bolk JH, Cohen AF. [Integration of training in pharmacology and pharmacotherapy in the medical curriculum in Leiden, the Netherlands]. Ned Tijdschr Geneeskd. 2004 Jan 24; 148(4):194-9.
-
Axelson O, Balbus JM, Cohen G, Davis D, Donnay A, Doolittle R, Duran BM, Egilman D, Epstein SS, Goldman L, Grandjean P, Hansen ES, Heltne P, Huff J, Infante P, Jacobson MF, Joshi TK, LaDou J, Landrigan PJ, Lee PR, Lockwood AH, MacGregor G, Melnick R, Messing K, Needleman H, Ozonoff D, Ravanesi B, Richter ED, Sass J, Schubert D, Suzuki D, Teitelbaum D, Temple NJ, Terracini B, Thompson A, Tickner J, Tomatis L, Upton AC, Whyatt RM, Wigmore D, Wilson T, Wing SB, Sharpe VA. Re: Regulatory Toxicology and Pharmacology. Int J Occup Environ Health. 2003 Oct-Dec; 9(4):386-9; author reply 389-90.
-
Minto CF, Schnider TW, Gregg KM, Henthorn TK, Shafer SL. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology. 2003 Aug; 99(2):324-33.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|